From the Field — JVIB Extract
Since From the Field features do not have abstracts, we have provided an extract of the beginning of the text.
Nanoparticles used to stem inflammation of retinal diseases
Researchers at Wayne State University, Mayo Clinic, and Johns Hopkins recently devised a potential treatment for macular degeneration and retinitis pigmentosa by using nanoparticles (called dendrimers) to deliver steroids to the retina. A collaborative research study demonstrated that steroids attached to dendrimers targeted the cells associated with neuroinflammation leaving the rest of the eye unaffected and preserving vision. (Neuroinflammation is an inflammatory response in the nervous system that causes the damage to the retina associated with dry age-related macular degeneration and retinitis pigmentosa.)<
Please log in if you wish to make a comment.
There are 0 comments on this article.
If you are a JVIB subscriber, please log in below. If you are an AER member, JVIB is part of your membership benefit: please visit AER's website to access JVIB.
Not yet a subscriber? Here are some options:
Purchase this individual article
Prefer not to subscribe?
Read FREE JVIB content or check out what JVIB has to offer.